ArticleNew microbes and new infections2021

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients.

F A Cadegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.